Trityl Irbesartan CAS 138402-10-5 Tsarkake>98.0% (HPLC) Irbesartan Intermediate Factory
Ruifu Chemical Supply Irbesartan Intermediates:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Tritil Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Side Chain Hydrochloride CAS 151257-01-1
Sunan Sinadari | Tril Irbesartan |
Makamantu | Triphenyl Irbesartan;Irbesartan N1-Trityl Rashin Tsabta;2-Butyl-3-(2'- (2-tryl-2H-tetrazol-5-yl)-[1,1'-biphenyl] -4-yl) methyl) -1,3-diazaspiro[4.4] -1-en-4-daya;2-Butyl-3-[4-[2- (2-tryl-tetrazol-5-yl) phenyl] methyl] -1,3-diazaspiro [4.4] ba-1-en-4-daya |
Lambar CAS | 138402-10-5 |
Lambar CAT | Saukewa: RF-PI1893 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C44H42N6O |
Nauyin Kwayoyin Halitta | 670.84 |
Yawan yawa | 1.20± 0.10 g/cm3 |
Wurin Tafasa | 834.6 ± 75.0 ℃ a 760 mmHg |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari zuwa Kashe-Farin Foda |
Tsarkake / Hanyar Bincike | 98.0% (HPLC) |
Asara akan bushewa | <1.00% |
Ragowa akan Ignition | <0.50% |
Rashin Tsabtace Guda Daya | <1.00% |
Jimlar ƙazanta | <2.00% |
Karfe masu nauyi | <20ppm |
Infrared Spectrum | Yayi daidai da Tsarin |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaici / Rashin Tsabta na Irbesartan (CAS: 138402-11-6) |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
Trityl Irbesartan (CAS: 138402-10-5) matsakaici ne ko ƙazanta na Irbesartan (CAS: 138402-11-6).Irbesartan shine angiotensin II receptor blocker (ARB) wanda aka nuna don: Maganin hauhawar jini, don rage hawan jini.Rage cutar hawan jini yana rage haɗarin haɗarin cututtukan zuciya da marasa mutuwa, da farko bugun jini da raunin zuciya.Jiyya na ciwon sukari nephropathy a cikin marasa lafiya masu fama da hauhawar jini tare da nau'in ciwon sukari na 2, creatinine mai haɓaka, da proteinuria.Sanofi Research ne ya haɓaka Irbesartan (yanzu ɓangaren Sanofi-Aventis).Sanofi-Aventis da Bristol-Myers Squibb ne ke tallata shi tare a ƙarƙashin sunayen kasuwancin Aprovel, Karvea, da Avapro.